Company Emyfarmalin S.r.l. with Fiscal Code 40599821
recorded a turnover of 2024 of
57.739,
with a net profit of
6.477
and having an average number of employees of
1.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Emyfarmalin S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
-
-
-
5.627
37.019
31.944
23.262
6.398
57.739
Total Income - EUR
-
-
-
-
5.627
37.185
32.325
23.262
6.398
57.739
Total Expenses - EUR
-
-
-
-
4.928
32.028
31.014
17.800
6.021
50.028
Gross Profit/Loss - EUR
-
-
-
-
699
5.157
1.311
5.462
377
7.711
Net Profit/Loss - EUR
-
-
-
-
642
4.813
727
4.800
316
6.477
Employees
-
-
-
-
1
1
1
0
0
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 807.5%, from 6.398 euro in the year 2023, to 57.739 euro in 2024.
The Net Profit increased by 6.162 euro, from 316 euro in 2023, to 6.477 in the last year.
Check the financial reports for the company - Emyfarmalin S.r.l.
Financial Rating - EMYFARMALIN S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Emyfarmalin S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Emyfarmalin S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Emyfarmalin S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
53.057 euro in 2024 which includes Inventories of
1.609 euro, Receivables of
42.515 euro and cash availability of
8.933 euro.
The company's Equity was valued at
17.607 euro, while total Liabilities amounted to
38.231 euro.
Equity increased by 6.477 euro, from 11.193 euro in 2023, to 17.607 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Emyfarmalin S.r.l.